Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Preclinical efficacy, safety, and immunogenicity of PHH-1... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Preclinical efficacy, safety, and immunogenicity of PHH-1V, a second-generation COVID-19 vaccine candidate based on a novel recombinant RBD fusion heterodimer of SARS-CoV-2.
0
Authors
Antonio Barreiro
52 more
Antonio Barreiro
•
Antoni Prenafeta
50 more
•
Laura Ferrer
Published
December 4, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Epidemiology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1101/2021.11.22.469117
License
cc-no
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Epidemiology
Medicine
Immunology
Internal Medicine
Show all topics
DOI
10.1101/2021.11.22.469117
License
cc-no
